AGN-151586 Dose-Ranging Study for Treatment of Glabellar Lines
Clinical trial NCT04096326 · COMPLETED
Trial details
- NCT number
- NCT04096326
- Sponsor
- Allergan
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2019-09-26
- Primary completion
- 2020-09-09
- Enrollment
- 198
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.